DIETARY_SUPPLEMENT · Unmapped registry intervention
folic acid 5 mg/cap
Find medicine records ·
Find other trials using this name
Clinical trial
Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia
NCT02916121
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPotential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
folic acid 5 mg/capDIETARY_SUPPLEMENT
PlaceboOTHER
Sponsors & collaborators
Taipei Medical University WanFang Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02916121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.